Ignite Creation Date:
2024-05-06 @ 1:14 AM
Last Modification Date:
2024-10-26 @ 11:01 AM
Study NCT ID:
NCT01764477
Status:
COMPLETED
Last Update Posted:
2017-08-17
First Post:
2012-12-12
Brief Title:
Safety and Efficacy Study of PRI-724 Plus Gemcitabine in Subjects With Advanced or Metastatic Pancreatic Adenocarcinoma
Sponsor:
Prism Pharma Co Ltd
Organization:
Prism Pharma Co Ltd
Organization Data
Organization:
Prism Pharma Co Ltd
Class:
INDUSTRY
Study ID:
PRI-724-102
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Prism Pharma Co Ltd
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| inVentiv Health Clinical | OTHER |